S'abonner

Inflammatory bowel disease and asthma. Results from the RHINE study - 08/07/23

Doi : 10.1016/j.rmed.2023.107307 
Marta A. Kisiel a, , Martin Sedvall b, Andrei Malinovschi c, Karl A. Franklin d, Thorarinn Gislason e, f, Vivi Shlunssen g, Ane Johansson h, Lars Modig i, Rain Jogi j, Mathias Holm k, Cecilia Svanes l, Louise Lindholdt g, Marie Carlson m, Christer Janson b
a Department of Medical Sciences: Environmental and Occupational Medicine, Uppsala University, Uppsala, Sweden 
b Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden 
c Department of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden 
d Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden 
e The Medical Faculty, University of Iceland, Reykjavik, Iceland 
f Department of Sleep, Landspitali University Hospital Reykjavik, Reykjavik, Iceland 
g Dept of Public Health, Danish Ramazzini Centre, Aarhus University and the National Research Centre for the Working Environment, Copenhagen, Denmark 
h Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway 
i Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden 
j The Lung Clinic, Tartu University Hospital, Tartu, Estonia 
k Section of Occupational and Environmental Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden 
l Dept of Global Public Health and Primary Care, Centre for International Health, University of Bergen, Bergen, Norway 
m Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden 

Corresponding author. Depart. of Medical Sciences: Environmental and Occupational Medicine, Uppsala University, 751 85, Uppsala, Sweden.Depart. of Medical Sciences: Environmental and Occupational MedicineUppsala UniversityUppsala751 85Sweden

Abstract

Background

Asthma and inflammatory bowel disease (IBD) are common inflammatory diseases. The aim of this study was to investigate the associations of IBD with asthma and respiratory symptoms.

Methods

This study is based on 13,499 participants from seven northern European countries that filled in a postal questionnaire on asthma, respiratory symptoms, IBD including ulcerative colitis and Crohn's disease and various lifestyle variables.

Results

There were 195 participants with IBD. The prevalence of asthma (14.5 vs 8.1%, p = 0.001), different respiratory symptoms (range 11.9–36.8% vs range 6.0–18.6%, p < 0.005), non-infectious rhinitis (52.1 vs. 41.6%, p = 0.004) and chronic rhinosinusitis (11.6 vs 6.0%, p = 0.001) were higher in subjects with IBD than in those without IBD. In multivariable regression analysis, the association between IBD and asthma was statistically significant (OR 1.95 (95% CI 1.28–2.96)) after adjusting for confounders such as sex, BMI, smoking history, educational level and physical activity. There was a significant association between asthma and ulcerative colitis (adjusted OR 2.02 (95% CI 1.27–2.19)), and asthma but not Crohn's disease (adjusted OR 1.66 (95% CI 0.69–3.95)). A significant gender interaction was found with a significant association between IBD and asthma in women but not in men ((OR 2.72 (95% CI 1.67–4.46) vs OR 0.87 (95% CI 0.35–2.19), p = 0.038).

Conclusions

Patients with IBD, particularly those with ulcerative colitis and female, have a higher prevalence of asthma and respiratory symptoms. Our findings indicate that it is important to consider respiratory symptoms and disorders when examining patients with manifest or suspected IBD.

Le texte complet de cet article est disponible en PDF.

Highlights

The prevalence of asthma and respiratory symptoms were higher in those with IBD compared to no IBD.
There was a significant association between asthma and ulcerative colitis.
A significant gender interaction was found with a link between IBD and asthma in women but not in men.

Le texte complet de cet article est disponible en PDF.

Keywords : Respiratory symptoms, Asthma, Inflammatory bowel disease, Ulcerative colitis and Crohn's disease


Plan


© 2023  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 216

Article 107307- septembre 2023 Retour au numéro
Article précédent Article précédent
  • Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE
  • Reynold A. Panettieri, Njira Lugogo, Wendy C. Moore, Bradley E. Chipps, Brett Jepson, Wenjiong Zhou, Christopher S. Ambrose, Eduardo Genofre, Donna D. Carstens
| Article suivant Article suivant
  • Lung abscess: Clinical characteristics of 222 Danish patients diagnosed from 2016 to 2021
  • Jakob Kirkegaard Vaarst, Søren Sperling, Victor Naestholt Dahl, Andreas Fløe, Christian Borbjerg Laursen, Tina Noerregaard Gissel, Pia Holland Gjoerup, Elisabeth Bendstrup

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.